October 25, 2014 8:40 AM ET

Healthcare Equipment and Supplies

Company Overview of Esaote SpA

Company Overview

Esaote SpA develops and produces products and solutions for non-invasive diagnostics and healthcare information technology applications. It offers ultrasound systems, probes, and transducers and kits for cardiovascular, general imaging, women's health, and point-of-care applications; dedicated MRI systems, such as musculoskeletal (MSK) MR imaging systems, weight-bearing MRI systems for MSK and spine imaging procedures, and coils; and healthcare IT products, such as RIS and CVIS PACS, radiotherapy, mammography, X-ray angiography, intravascular, magnetic resonance quantitative analysis, and structural heart and endovascular software products. The company also provides interventional and mini-i...

Via A. Siffredi, 58

Genoa, GE 16153

Italy

Founded in 1988

1,067 Employees

Phone:

39 01 065471

Fax:

39 01 06 54 72 75

Key Executives for Esaote SpA

Chief Executive Officer
Chief Financial Officer
Age: 46
Group Chief Operations Officer
Age: 54
Chief Global Marketing & Domestic Sales Officer and Director
Chief Technology Officer
Compensation as of Fiscal Year 2014.

Esaote SpA Key Developments

ESAOTE Announces the Launch of Two New Ultrasound Systems: MyLabTMSix and MyLabTMGamma

ESAOTE announced the launch of two new ultrasound machines, confirming its position as an innovator in the global ultrasound imaging market, and delivering affordable productivity, efficiency and value. MyLabTMSix and MyLabTMGamma have been developed to address key sectors of the imaging market, reinforcing ESAOTE's global ultrasound portfolio – from application-specific to fully shared services. MyLabTMSix is a cart-based ultrasound system providing highly ergonomic, low on noise and `green' product solutions. Configured for an extensive range of applications, it delivers a premium quality, yet affordable, solution for shared ultrasound services across any busy clinical setting. MyLabTMGamma is a best in class, highly-portable, `green' ultrasound system. Based on Esaote's productivity-oriented operating platform, the super-light, feature packed portable system sets ultrasound free to be used in any environment at a moment's notice, from point-of-care to shared service solutions. MyLabTMSix is a complete cart-based system that can be used across a broad range of applications from general imaging to women's health and cardiovascular. It comes with highly advanced scanning features, combining to ensure complete confidence in any diagnosis. This system delivers software and probes from dedicated-to-application to fully shared service solutions, including advanced applications. Highly portable and battery-operated, the MyLabTMGamma offers fast boot times and a rapid resume from standby mode which means the system is ready to use within seconds. Integration of wireless connectivity, a class feature for a system of its size and price, facilitates easy, one-click networking with other systems and local networks as required. Esaote will introduce MyLabTMSix and MyLabTMGamma in the EMEA market at the European Society of Cardiology 2014 congress (Barcelona) in August, followed by ESRA (Seville), ISUOG (Barcelona) in September and JFR (Paris) in October.

Esaote Launches CrystaLine to Deliver New Levels of Accuracy, Quality, Versatility and Value

Esaote launched CrystaLine, a significant evolution of its ultrasound technology that delivers new levels of accuracy, quality, versatility and value. CrystaLine's superior technical capabilities enable high quality images to be captured at greater depth in the body. This significant improvement overcomes the challenges associated with larger and difficult to scan patients. CrystaLine incorporates specific hardware and software features that build on the advanced eHD ultrasound technology the company introduced last year. The reality of higher quality, clearer imaging at increased depth, now enables clinicians to confidently use ultrasound in borderline examinations and interventional ultrasound procedures. Major technical improvements provided by CrystaLine include Combined Pulse Imaging Technology which effectively increases depth-of-field, improving the imaging of structures deeper in the body. Combined with the new XView+ speckle-noise reduction system, fully adjustable by the operator, helps to produce an optimal personalised image. Esaote systems with CrystaLine are also able to synchronise in real-time with therapeutic applications. The new eXP Technology upgrade for Esaote's Dedicated MRI systems enables faster examinations and increased diagnostic confidence. eXP Technology will be showcased on the O-scan and G-scan Brio to demonstrate enhanced image quality. SUITESTENSA RIS PACS advanced information will also be unveiled at ECR. Suitestensa now includes second-generation Structured Report functionalities and 3D applications. Mobile PACs enables off-site access to images. Esaote MyLab(TM) Twice, Seven and Alpha systems are showcased with CrystaLine at ECR 2014 together with the eXP Technology on G-scan brio and O-scan. CrystaLine and eXP Technology will be available as an upgrade to existing versions of these.

Similar Private Companies By Industry

Company Name Region
LTL SPA Europe
Cizeta Surgical Srl Europe
Becton, Dickinson Italia S.p.A. Europe
Allison S.p.A. Europe
Desil SpA Europe

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
July 14, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Esaote SpA, please visit www.esaote.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.